Two new studies examine the health and outcomes of patients with COVID-19 who have undergone kidney transplantation or are receiving hemodialysis. The findings appear in an upcoming issue of CJASN.
Jul 7, 2020
0
5
Australia must prepare for the "aftershocks" from COVID-19 or risk leaving survivors of the virus struggling to rehabilitate, according to the authors of a Perspective published online today by the Medical Journal of Australia.
Jul 6, 2020
0
1
Clinician scientists at RCSI University of Medicine and Health Sciences have begun a clinical trial of a promising therapy for critically ill COVID-19 patients in intensive care.
Jun 29, 2020
0
2
A new paper published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory ...
Jun 5, 2020
0
0
Glucocorticoids are widely used in treating acute respiratory distress syndrome (ARDS) despite there being no indisputable scientific evidence of their effectiveness. The main reason seems to be that there is no effective ...
May 29, 2020
0
0
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) ...
May 8, 2020
0
31
A device designed at the University of Pittsburgh could help improve outcomes as a treatment for COVID-19 when used in conjunction with non-invasive or mechanical ventilation, and it recently received Emergency Use Authorization ...
Apr 28, 2020
0
3
The new coronavirus's ability to wreak havoc in the lungs is raising a lot of concerns and questions from my asthma patients. They already know how it feels to have trouble breathing. Now, they are wondering what risks they ...
Apr 10, 2020
0
6
An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment. ...
Apr 6, 2020
0
0
The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced ...
Mar 26, 2020
0
5
